Incidental finding of non-Hodgkin's lymphoma in a patient affected by castration-sensitive prostate cancer: A case report

por Pirozzi, Angelo, Cartenì, Giacomo, Scagliarini, Sarah, Fusco, Mario, Riccardi, Ferdinando
Publicado no Medicine (Baltimore) (2019)

Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract: A case report

por Pirozzi, Angelo, Riccardi, Ferdinando, Arpino, Grazia, Mocerino, Carmela, Campione, Severo, Molino, Carlo, Cartenì, Giacomo
Publicado no Medicine (Baltimore) (2019)

Second-line treatment in renal cell carcinoma: clinical experience and decision making

por Guadalupi, Valentina, Cartenì, Giacomo, Iacovelli, Roberto, Porta, Camillo, Pappagallo, Giovanni, Ricotta, Riccardo, Procopio, Giuseppe
Publicado no Ther Adv Urol (2021)

Erlotinib-induced complete response in a patient with epidermal growth factor receptor wild-type lung adenocarcinoma after chemotherapy failure: a case report

por Vitale, Maria Giuseppa, Riccardi, Ferdinando, Mocerino, Carmela, Barbato, Carmela, Monaco, Roberto, Galloro, Paola, Gagliardi, Nicola, Cartenì, Giacomo
Publicado em 2014

Severe blood loss anaemia and recurrent intussusceptions as first presentation of bowel metastatic renal cell carcinoma: A case report and review of the literature

por Trojaniello, Claudia, Vitale, Maria Giuseppa, Trojaniello, Biagio, Lentini Graziano, Maria Luisa, Coccaro, Mariarosa, Cartenì, Giacomo, Montesarchio, Vincenzo
Publicado no Mol Clin Oncol (2017)

The 2nd meeting of the Campania Society of Oncology Immunotherapy (SCITO): focus on hepatocellular carcinoma, kidney and bladder cancer

por Daniele, Bruno, Sangro, Bruno, Petrylak, Daniel, Calabrò, Fabio, Cartenì, Giacomo, Montesarchio, Vincenzo, De Placido, Sabino, Ascierto, Paolo A.
Publicado no J Immunother Cancer (2016)

Clinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinib

por Iacovelli, Roberto, Cartenì, Giacomo, Milella, Michele, Berardi, Rossana, Di Lorenzo, Giuseppe, Verzoni, Elena, Rizzo, Mimma, Santoni, Matteo, Procopio, Giuseppe
Publicado em 2014

Anemia prevalence and treatment practice in patients with non-myeloid tumors receiving chemotherapy

por Merlini, Laura, Cartenì, Giacomo, Iacobelli, Stefano, Stelitano, Caterina, Airoldi, Mario, Balcke, Peter, Keil, Felix, Haslbauer, Ferdinand, Belton, Laura, Pujol, Beatriz
Publicado em 2013

Pancreatic solitary and synchronous metastasis from breast cancer: a case report and systematic review of controversies in diagnosis and treatment

por Molino, Carlo, Mocerino, Carmela, Braucci, Antonio, Riccardi, Ferdinando, Trunfio, Martino, Carrillo, Giovanna, Vitale, Maria Giuseppa, Cartenì, Giacomo, De Sena, Guido
Publicado em 2014

Cost of illness of urothelial bladder cancer in Italy

por Gerace, Claudio, Montorsi, Francesco, Tambaro, Rosa, Cartenì, Giacomo, De Luca, Stefano, Tucci, Marcello, Martorana, Giuseppe, Basso, Umberto, Cardosi, Leonardo, Teruzzi, Cristina
Publicado no Clinicoecon Outcomes Res (2017)

Pathological complete response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer

por Riccardi, Ferdinando, Di Lorenzo, Giuseppe, Buonerba, Carlo, Monaco, Guglielmo, Monaco, Roberto, Rizzo, Mimma, Scagliarini, Sarah, Scognamiglio, Florinda, Di Napoli, Marilena, Carteni', Giacomo
Publicado em 2010

ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy

por Vitale, Maria Giuseppa, Barbato, Carmela, Crispo, Anna, Habetswallner, Francesco, De Martino, Bernardo Maria, Riccardi, Ferdinando, Maione, Angela, Eisenwagen, Sandra, Vitale, Giovanna, Cartenì, Giacomo
Publicado no Molecules (2020)

What have we learned from immunotherapy? Report from the 3rd and 4th meetings of the Campania Society of Oncology Immunotherapy (SCITO)

por Ascierto, Paolo Antonio, Cartenì, Giacomo, Gridelli, Cesare, Pignata, Sandro, Pinto, Antonio, Criscitiello, Carmen, Buonaguro, Luigi, Pepe, Stefano, Mabilia, Roberto, Montesarchio, Vincenzo, Daniele, Bruno, De Placido, Sabino
Publicado no J Immunother Cancer (2016)

The role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014

por Ascierto, Paolo A, Addeo, Raffaele, Cartenì, Giacomo, Daniele, Bruno, De Laurentis, Michele, Ianniello, Giovanni Pietro, Morabito, Alessandro, Palmieri, Giovannella, Pepe, Stefano, Perrone, Francesco, Pignata, Sandro, Montesarchio, Vincenzo
Publicado em 2014

Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Regi...

por Riccardi, Ferdinando, Colantuoni, Giuseppe, Diana, Anna, Mocerino, Carmela, Cartenì, Giacomo, Lauria, Rossella, Febbraro, Antonio, Nuzzo, Francesco, Addeo, Raffaele, Marano, Ombretta, Incoronato, Pasquale, De Placido, Sabino, Ciardiello, Fortunato, Orditura, Michele
Publicado no Mol Clin Oncol (2018)

Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma

por Rossetti, Sabrina, D'Aniello, Carmine, Iovane, Gelsomina, Scagliarini, Sarah, Laterza, Maria M., De Vita, Fernando, Savastano, Clementina, Cartenì, Giacomo, Porricelli, Maria A., Berretta, Massimiliano, Pisconti, Salvatore, Facchini, Gaetano, Cavaliere, Carla
Publicado no Front Pharmacol (2017)

AT-11 FINAL RESULTS FROM THE RANDOMIZED PHASE II TRIAL AVAREG (ML25739) WITH BEVACIZUMAB (BEV) OR FOTEMUSTINE (FTM) IN RECURRENT GBM

por Brandes, Alba A., Finocchiaro, Gaetano, Zagonel, Vittorina, Reni, Michele, Fabi, Alessandra, Caserta, Claudia, Clavarezza, Matteo, Maiello, Evaristo, Cartenì, Giacomo, Rosti, Giovanni, Eoli, Marica, Lombardi, Giuseppe, Monteforte, Marta, Agati, Raffaele, Eusebi, Vincenzo, Galli, Anna, Doria, Simona, Franceschi, Enrico
Publicado em 2014

NI-26 COMPARATIVE ANALYSIS OF THE RANO AND MACDONAD'S CRITERIA IN RECURRENT GLIOBLASTOMA TREATED IN THE RANDOMIZED PHASE II TRIAL AVAREG WITH BEVACIZUMAB OR FOTEMUSTINE.

por Franceschi, Enrico, Agati, Raffaele, Finocchiaro, Gaetano, Zagonel, Vittorina, Fabi, Alessandra, Reni, Michele, Caserta, Claudia, Maiello, Evaristo, Cartenì, Giacomo, Clavarezza, Matteo, Rosti, Giovanni, Eoli, Marica, Lombardi, Giuseppe, Bacci, Antonella, Monteforte, Marta, Doria, Simona, Galli, Anna, Brandes, Alba A.
Publicado em 2014

Prognostic and Predictive Factors in Patients with Advanced Penile Cancer Receiving Salvage (2nd or Later Line) Systemic Treatment: A Retrospective, Multi-Center Study

por Buonerba, Carlo, Di Lorenzo, Giuseppe, Pond, Gregory, Cartenì, Giacomo, Scagliarini, Sarah, Rozzi, Antonio, Quevedo, Fernando J., Dorff, Tanya, Nappi, Lucia, Lanzetta, Gaetano, Pagliaro, Lance, Eigl, Bernhard J., Naik, Gurudatta, Ferro, Matteo, Galdiero, Mariano, De Placido, Sabino, Sonpavde, Guru
Publicado no Front Pharmacol (2016)

PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide: A retrospective case-report study

por Bosso, Davide, Pagliuca, Martina, Sonpavde, Guru, Pond, Gregory, Lucarelli, Giuseppe, Rossetti, Sabrina, Facchini, Gaetano, Scagliarini, Sarah, Cartenì, Giacomo, Daniele, Bruno, Morelli, Franco, Ferro, Matteo, Puglia, Livio, Izzo, Michela, Montanaro, Vittorino, Bellelli, Teresa, Vitrone, Francesca, De Placido, Sabino, Buonerba, Carlo, Di Lorenzo, Giuseppe
Publicado no Medicine (Baltimore) (2017)